Clinical Trial Update: Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thymosin alpha-1 and/or interferon alpha in combination with dacarbazine for malignant melanoma; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Interferon-alpha (interferon alpha)
• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2009-06-02